title: Sclerosing encapsulating peritonitis after renal transplantation. Does it make sense?
authors.affiliation: Renal Transplant Unit, Hospital das Clínicas, University of São Paulo, Brazil.
authors.forename: D J
authors.initials: DJ
authors.lastname: Machado
authors.forename: C S
authors.initials: CS
authors.lastname: Cocuzza
authors.forename: W C
authors.initials: WC
authors.lastname: Nahas
authors.forename: L E
authors.initials: LE
authors.lastname: Ianhez
mesh_terms: D000328:Adult; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007676:Kidney Failure, Chronic / Q000601:surgery* / Q000628:therapy; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000379:methods; D007813:Laparotomy; D008297:Male; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000379:methods; D010538:Peritonitis / Q000175:diagnosis* / Q000209:etiology* / Q000601:surgery; D012086:Reoperation; D012598:Sclerosis / Q000000981:diagnostic imaging / Q000209:etiology / Q000601:surgery; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome